{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:48:47Z","timestamp":1790704127685,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Narcolepsy type 1 (NT1) is a chronic neurological disorder having a strong association with HLA-DQB1*0602, thereby suggesting an immunological origin. Increased risk of NT1 has been reported among children or adolescents vaccinated with AS03 adjuvant-supplemented pandemic H1N1 influenza A vaccine, Pandemrix. Here we show that pediatric Pandemrix-associated NT1 patients have enhanced T-cell immunity against the viral epitopes, neuraminidase 175\u2013189 (NA<jats:sub>175\u2013189<\/jats:sub>) and nucleoprotein 214\u2013228 (NP<jats:sub>214\u2013228<\/jats:sub>), but also respond to a NA<jats:sub>175\u2013189<\/jats:sub>-mimic, brain self-epitope, protein-O-mannosyltransferase 1 (POMT1<jats:sub>675\u2013689<\/jats:sub>). A pathogenic role of influenza virus-specific T-cells and T-cell cross-reactivity in NT1 are supported by the up-regulation of IFN-\u03b3, perforin 1 and granzyme B, and by the converging selection of T-cell receptor TRAV10\/TRAJ17 and TRAV10\/TRAJ24 clonotypes, in response to stimulation either with peptide NA<jats:sub>175\u2013189<\/jats:sub> or POMT1<jats:sub>675\u2013689<\/jats:sub>. Moreover, anti-POMT1 serum autoantibodies are increased in Pandemrix-vaccinated children or adolescents. These results thus identify POMT1 as a potential autoantigen recognized by T- and B-cells in NT1.<\/jats:p>","DOI":"10.1038\/s41467-021-22637-8","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T11:36:09Z","timestamp":1618572969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1"],"prefix":"10.1038","volume":"12","author":[{"given":"A.","family":"Vuorela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-2991","authenticated-orcid":false,"given":"T. L.","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Leskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Pessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"H\u00e4rk\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Stracenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kirjavainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Saarenp\u00e4\u00e4-Heikkil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ilonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0474-0033","authenticated-orcid":false,"given":"M.","family":"Knip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Partinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Saavalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Meri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Vaarala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"22637_CR1","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMra1500587","volume":"373","author":"TE Scammell","year":"2015","unstructured":"Scammell, T. E. Narcolepsy. N. Engl. J. Med. 373, 2654\u20132662 (2015).","journal-title":"N. Engl. J. Med."},{"key":"22637_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","volume":"369","author":"Y Dauvilliers","year":"2007","unstructured":"Dauvilliers, Y., Arnulf, I. & Mignot, E. Narcolepsy with cataplexy. Lancet 369, 499\u2013511 (2007).","journal-title":"Lancet"},{"key":"22637_CR3","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S1474-4422(14)70075-4","volume":"13","author":"M Partinen","year":"2014","unstructured":"Partinen, M. et al. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol. 13, 600\u2013613 (2014).","journal-title":"Lancet Neurol."},{"key":"22637_CR4","first-page":"1012","volume":"20","author":"E Mignot","year":"1997","unstructured":"Mignot, E., Hayduk, R., Black, J., Grumet, F. C. & Guilleminault, C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 20, 1012\u20131020 (1997).","journal-title":"Sleep"},{"key":"22637_CR5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/ng.372","volume":"41","author":"J Hallmayer","year":"2009","unstructured":"Hallmayer, J. et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat. Genet. 41, 708\u2013711 (2009).","journal-title":"Nat. Genet."},{"key":"22637_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1034\/j.1399-0039.1999.540204.x","volume":"54","author":"H Hohjoh","year":"1999","unstructured":"Hohjoh, H. et al. Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha gene promoter with human narcolepsy. Tissue Antigens 54, 138\u2013145 (1999).","journal-title":"Tissue Antigens"},{"key":"22637_CR7","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1034\/j.1399-0039.2000.560508.x","volume":"56","author":"H Hohjoh","year":"2000","unstructured":"Hohjoh, H., Terada, N., Kawashima, M., Honda, Y. & Tokunaga, K. Significant association of the tumor necrosis factor receptor 2 gene with human narcolepsy. Tissue Antigens 56, 446\u2013448 (2000).","journal-title":"Tissue Antigens"},{"key":"22637_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/ng.734","volume":"43","author":"BR Kornum","year":"2011","unstructured":"Kornum, B. R. et al. Common variants in P2RY11 are associated with narcolepsy. Nat. Genet. 43, 66\u201371 (2011).","journal-title":"Nat. Genet."},{"key":"22637_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/79690","volume":"6","author":"C Peyron","year":"2000","unstructured":"Peyron, C. et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6, 991\u2013997 (2000).","journal-title":"Nat. Med."},{"key":"22637_CR10","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/brain\/awq086","volume":"133","author":"A Fontana","year":"2010","unstructured":"Fontana, A. et al. Narcolepsy: Autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss? Brain 133, 1300\u20131311 (2010).","journal-title":"Brain"},{"key":"22637_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1474-4422(14)70218-2","volume":"14","author":"RS Liblau","year":"2015","unstructured":"Liblau, R. S., Vassalli, A., Seifinejad, A. & Tafti, M. Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Lancet Neurol. 14, 318\u2013328 (2015).","journal-title":"Lancet Neurol."},{"key":"22637_CR12","doi-asserted-by":"publisher","first-page":"e33723","DOI":"10.1371\/journal.pone.0033723","volume":"7","author":"M Partinen","year":"2012","unstructured":"Partinen, M. et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS ONE 7, e33723 (2012).","journal-title":"PLoS ONE"},{"key":"22637_CR13","doi-asserted-by":"publisher","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","volume":"7","author":"H Nohynek","year":"2012","unstructured":"Nohynek, H. et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 7, e33536 (2012).","journal-title":"PLoS ONE"},{"key":"22637_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1473-3099(13)70238-X","volume":"14","author":"CI Barker","year":"2014","unstructured":"Barker, C. I. & Snape, M. D. Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action. Lancet Infect. Dis. 14, 227\u2013238 (2014).","journal-title":"Lancet Infect. Dis."},{"key":"22637_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.smrv.2017.06.006","volume":"38","author":"TO Sarkanen","year":"2018","unstructured":"Sarkanen, T. O., Alakuijala, A. P. E., Dauvilliers, Y. A. & Partinen, M. M. Incidence of narcolepsy after H1N1 influenza and vaccination: Systematic review and meta-analysis. Sleep. Med Rev. 38, 177\u2013186 (2018).","journal-title":"Sleep. Med Rev."},{"key":"22637_CR16","doi-asserted-by":"publisher","first-page":"e114361","DOI":"10.1371\/journal.pone.0114361","volume":"9","author":"O Vaarala","year":"2014","unstructured":"Vaarala, O. et al. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: Implications for Pandemrix-associated narcolepsy risk. PLoS ONE 9, e114361 (2014).","journal-title":"PLoS ONE"},{"key":"22637_CR17","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.4049\/jimmunol.176.12.7715","volume":"176","author":"SL Hayward","year":"2006","unstructured":"Hayward, S. L. et al. CD4 T cells play a major effector role and CD8 T cell initiating role in spontaneous autoimmune myocarditis of HLA-DQ8 transgenic IAb knockout nonobese diabetic mice. J. Immunol. 176, 7715\u20137725 (2006).","journal-title":"J. Immunol."},{"key":"22637_CR18","doi-asserted-by":"publisher","first-page":"E12323","DOI":"10.1073\/pnas.1818150116","volume":"115","author":"G Luo","year":"2018","unstructured":"Luo, G. et al. Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy. Proc. Natl Acad. Sci. USA 115, E12323\u2013E12332 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"22637_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ebiom.2018.01.043","volume":"29","author":"H Sadam","year":"2018","unstructured":"Sadam, H. et al. Prostaglandin D2 receptor DP1 antibodies predict vaccine-induced and spontaneous narcolepsy type 1: large-scale study of antibody profiling. EBioMedicine 29, 47\u201359 (2018).","journal-title":"EBioMedicine"},{"key":"22637_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jcv.2019.08.009","volume":"119","author":"JM Jansen","year":"2019","unstructured":"Jansen, J. M., Gerlach, T., Elbahesh, H., Rimmelzwaan, G. F. & Saletti, G. Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. J. Clin. Virol. 119, 44\u201352 (2019).","journal-title":"J. Clin. Virol."},{"key":"22637_CR21","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s001250051067","volume":"41","author":"K Savola","year":"1998","unstructured":"Savola, K. et al. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children. Diabetologia 41, 1293\u20131297 (1998).","journal-title":"Diabetologia"},{"key":"22637_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri1805","volume":"6","author":"EY Jones","year":"2006","unstructured":"Jones, E. Y., Fugger, L., Strominger, J. L. & Siebold, C. MHC class II proteins and disease: a structural perspective. Nat. Rev. Immunol. 6, 271\u2013282 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"22637_CR23","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1212\/WNL.50.4.1149","volume":"50","author":"D Hinze-Selch","year":"1998","unstructured":"Hinze-Selch, D. et al. In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls. Neurology 50, 1149\u20131152 (1998).","journal-title":"Neurology"},{"key":"22637_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ajhg.2014.12.010","volume":"96","author":"HM Ollila","year":"2015","unstructured":"Ollila, H. M. et al. HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. Am. J. Hum. Genet. 96, 136\u2013146 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"22637_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.5665\/sleep.5532","volume":"39","author":"M Tafti","year":"2016","unstructured":"Tafti, M. et al. Narcolepsy-associated HLA class I alleles implicate cell-mediated cytotoxicity. Sleep 39, 581\u2013587 (2016).","journal-title":"Sleep"},{"key":"22637_CR26","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1016\/j.febslet.2011.08.047","volume":"585","author":"A Saxena","year":"2011","unstructured":"Saxena, A., Martin-Blondel, G., Mars, L. T. & Liblau, R. S. Role of CD8+ T cell subsets in the pathogenesis of multiple sclerosis. FEBS Lett. 585, 3758\u20133763 (2011).","journal-title":"FEBS Lett."},{"key":"22637_CR27","doi-asserted-by":"publisher","first-page":"e1003880","DOI":"10.1371\/journal.pgen.1003880","volume":"9","author":"F Han","year":"2013","unstructured":"Han, F. et al. Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic. PLoS Genet. 9, e1003880 (2013).","journal-title":"PLoS Genet."},{"key":"22637_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13234-x","volume":"10","author":"W Jiang","year":"2019","unstructured":"Jiang, W. et al. In vivo clonal expansion and phenotypes of hypcretin-specific CD4+ T cells in narcolepsy patients and controls. Nat. Commun. 10, 5247 (2019).","journal-title":"Nat. Commun."},{"key":"22637_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jneuroim.2019.04.009","volume":"332","author":"MS Schinkelshoek","year":"2019","unstructured":"Schinkelshoek, M. S. et al. H1N1 hemagglutinin-specific HLA-DQ6-restricted CD4+ T cells can be readily detected in narcolepsy type 1 patients and healthy controls. J. Neuroimmunol. 332, 167\u2013175 (2019).","journal-title":"J. Neuroimmunol."},{"key":"22637_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41586-018-0540-1","volume":"562","author":"D Latorre","year":"2018","unstructured":"Latorre, D. et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 562, 63\u201368 (2018).","journal-title":"Nature"},{"key":"22637_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mrrev.2018.09.002","volume":"778","author":"P Hu","year":"2018","unstructured":"Hu, P., Yuan, L. & Deng, H. Molecular genetics of the POMT1-related muscular dystrophy-dystroglycanopathies. Mutat. Res. 778, 45\u201350 (2018).","journal-title":"Mutat. Res."},{"key":"22637_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.smrv.2012.01.001","volume":"16","author":"YA Dauvilliers","year":"2012","unstructured":"Dauvilliers, Y. A. & Laberge, L. Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation. Sleep. Med. Rev. 16, 539\u2013545 (2012).","journal-title":"Sleep. Med. Rev."},{"key":"22637_CR33","unstructured":"International classification of sleep disorders, 3rd edn. ICSD-3 (American Academy of Sleep Medicine, Darien, IL, USA, 2014)"},{"key":"22637_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.humimm.2013.09.008","volume":"75","author":"ML Mikk","year":"2014","unstructured":"Mikk, M. L. et al. The HLA-B*39 allele increases type 1 diabetes risk conferred by HLA-DRB1*04:04-DQB1*03:02 and HLA-DRB1*08-DQB1*04 class II haplotypes. Hum. Immunol. 75, 65\u201370 (2014).","journal-title":"Hum. Immunol."},{"key":"22637_CR35","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.3389\/fimmu.2018.02701","volume":"9","author":"E Nissil\u00e4","year":"2018","unstructured":"Nissil\u00e4, E. et al. Complement factor H and apolipoprotein E participate in regulation of inflammation in THP-1 macrophages. Front. Immunol. 9, 2701 (2018).","journal-title":"Front. Immunol."},{"key":"22637_CR36","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","volume":"161","author":"EZ Macosko","year":"2015","unstructured":"Macosko, E. Z. et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202\u20131214 (2015).","journal-title":"Cell"},{"key":"22637_CR37","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1053\/j.gastro.2020.01.045","volume":"158","author":"TL Freitag","year":"2020","unstructured":"Freitag, T. L. et al. Gliadin nanoparticles induce immune tolerance to gliadin in mouse models of celiac disease. Gastroenterology 158, 1667\u20131681 (2020).","journal-title":"Gastroenterology"},{"key":"22637_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"22637_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. EdgeR: A bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"22637_CR40","doi-asserted-by":"publisher","first-page":"W147","DOI":"10.1093\/nar\/gkw419","volume":"44","author":"S Babicki","year":"2016","unstructured":"Babicki, S. et al. Heatmapper: Web-enabled heat mapping for all. Nucleic Acids Res. 44, W147\u2013W153 (2016).","journal-title":"Nucleic Acids Res."},{"key":"22637_CR41","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser, A. et al. Primer3-new capabilities and interfaces. Nucleic Acids Res. 40, e115 (2012).","journal-title":"Nucleic Acids Res."},{"key":"22637_CR42","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/bioinformatics\/btm091","volume":"23","author":"T Koressaar","year":"2007","unstructured":"Koressaar, T. & Remm, M. Enhancements and modifications of primer design program Primer3. Bioinformatics 23, 1289\u20131291 (2007).","journal-title":"Bioinformatics"},{"key":"22637_CR43","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/nbt.3979","volume":"35","author":"DA Bolotin","year":"2017","unstructured":"Bolotin, D. A. et al. Antigen receptor repertoire profiling from RNA-seq data. Nat. Biotechnol. 35, 908\u2013911 (2017).","journal-title":"Nat. Biotechnol."},{"key":"22637_CR44","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nmeth.3364","volume":"12","author":"DA Bolotin","year":"2015","unstructured":"Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380\u2013381 (2015).","journal-title":"Nat. Methods"},{"key":"22637_CR45","doi-asserted-by":"publisher","first-page":"e1004503","DOI":"10.1371\/journal.pcbi.1004503","volume":"11","author":"M Shugay","year":"2015","unstructured":"Shugay, M. et al. VDJtools: unifying post-analysis of T cell receptor repertoires. PLoS Comput. Biol. 11, e1004503 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"22637_CR46","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1093\/bioinformatics\/btx292","volume":"33","author":"F Del Carratore","year":"2017","unstructured":"Del Carratore, F. et al. RankProd 2.0: a refactored bioconductor package for detecting differentially expressed features in molecular profiling datasets. Bioinformatics 33, 2774\u20132775 (2017).","journal-title":"Bioinformatics"},{"key":"22637_CR47","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1093\/bioinformatics\/btl476","volume":"22","author":"F Hong","year":"2006","unstructured":"Hong, F. et al. RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22, 2825\u20132827 (2006).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22637-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22637-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22637-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T11:38:09Z","timestamp":1669981089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22637-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["22637"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-22637-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,16]]},"assertion":[{"value":"7 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"O.V. is an employee of Orion Pharma since June 2019 and was an employee of AstraZeneca\/Medimmune from August 2014 to June 2019. This research was started before she joined AstraZeneca, and neither Orion Pharma nor AstraZeneca have a role in this study. M.P. is a member of the Medical Advisory Board of Bioprojet and UCB Pharma. He has been involved in clinical trials on narcolepsy with Bioprojet, Jazz Pharmaceuticals, and UCB Pharma. These roles are not related to this research project. I.S. is an employee of Janssen Pharmaceuticals. This research was started before she joined Janssen, and Janssen has no role in this study. P.S is the CEO and board chair of SCellex, which has no role in this study. K.L. and H.P. are employees of SCellex. The other authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2283"}}